Evidence map›Paper›PMID 41925005›Full record

ReviewInternational journal of laboratory hematology2026

Laboratory and Medicine 2.1: Care for What You Wish for.

Marcel Levi

Abstract readReview
In one paragraph

Review in International journal of laboratory hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Marcel LeviDepartment of Vascular Medicine, Amsterdam University Medical Center (Location Academic Medical Center), University of Amsterdam, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-2212-5299

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few decades, healthcare has made remarkable advances. Across nearly all fields, diseases are better understood, and diagnostic and therapeutic options have expanded dramatically. Laboratory medicine is also developing at a rapid pace and is playing an increasingly central role in the diagnostic process, as well as in the monitoring of therapy and disease progression. For many conditions-including cardiovascular disease and cancer-patient outcomes have improved spectacularly. However, this success has also created new challenges. Death from acute illness has increasingly been replaced by survival with chronic disease. An aging-though not necessarily healthy-population demands substantial personal, financial, and organizational support. Hyperspecialization is poorly suited to meeting these complex needs. Moreover, efficiency-driven centralization of care, encompassing both clinical services and laboratories, may be necessary but often introduces new problems that can only be addressed through innovation and technology. Most importantly, strong professional leadership is essential. With healthcare professionals in the lead, we can ensure a resilient and sustainable healthcare system, supported by high-quality laboratory services, in which complex issues such as superspecialization, centralization, and efficiency are addressed in an optimal and integrated manner.

Indexed as

Delivery of Health CareLaboratories, ClinicalHumans

Identifiers

PMID41925005
PMCPMC13357740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.